Articles with public access mandates - PRAKASH G. KSHIRSAGARLearn more
Available somewhere: 14
Absolute and direct microRNA quantification using DNA–gold nanoparticle probes
F Degliangeli, P Kshirsagar, V Brunetti, PP Pompa, R Fiammengo
Journal of the American Chemical Society 136 (6), 2264-2267, 2014
Mandates: Government of Italy
Label-free characterization of exosome via surface enhanced Raman spectroscopy for the early detection of pancreatic cancer
J Carmicheal, C Hayashi, X Huang, L Liu, Y Lu, A Krasnoslobodtsev, ...
Nanomedicine: Nanotechnology, Biology and Medicine 16, 88-96, 2019
Mandates: US National Institutes of Health
Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies
L Liu, PG Kshirsagar, SK Gautam, M Gulati, EI Wafa, JC Christiansen, ...
Theranostics 12 (3), 1030, 2022
Mandates: US National Institutes of Health
Direct-written polymer field-effect transistors operating at 20 MHz
A Perinot, P Kshirsagar, MA Malvindi, PP Pompa, R Fiammengo, ...
Scientific reports 6 (1), 38941, 2016
Mandates: European Commission
MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4/FOXM1/RRM2 axis
P Khan, JA Siddiqui, PG Kshirsagar, RC Venkata, SK Maurya, ...
Molecular cancer 22 (1), 1, 2023
Mandates: US Department of Defense, US National Institutes of Health
Sildenafil potentiates the therapeutic efficacy of docetaxel in advanced prostate cancer by stimulating NO-cGMP signaling
S Muniyan, S Rachagani, S Parte, S Halder, P Seshacharyulu, ...
Clinical Cancer Research 26 (21), 5720-5734, 2020
Mandates: US Department of Defense, US National Institutes of Health
Polyanhydride nanoparticles stabilize pancreatic cancer antigen MUC4β
L Liu, P Kshirsagar, J Christiansen, SK Gautam, A Aithal, M Gulati, ...
Journal of Biomedical Materials Research Part A 109 (6), 893-902, 2021
Mandates: US National Institutes of Health
Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer
MJ Abhijit Aithal, Wade M Junker, Prakash Kshirsagar, Srustidhar Das ...
PloS one 13 (4), e0193907, 2018
Mandates: US National Institutes of Health
Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells
K Banerjee, SK Gautam, P Kshirsagar, KA Ross, G Spagnol, P Sorgen, ...
Genes & cancer 10 (3-4), 52, 2019
Mandates: US National Institutes of Health
The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights
S Halder, S Parte, P Kshirsagar, S Muniyan, HB Nair, SK Batra, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1877 (4), 188737, 2022
Mandates: US Department of Defense, US National Institutes of Health
DNA-gold nanoprobe-based integrated biosensing technology for non-invasive liquid biopsy of serum miRNA: A new frontier in prostate cancer diagnosis
P Kshirsagar, P Seshacharyulu, S Muniyan, S Rachagani, LM Smith, ...
Nanomedicine: Nanotechnology, Biology and Medicine 43, 102566, 2022
Mandates: US Department of Defense, US National Institutes of Health
Chimeric antibody targeting unique epitope on onco-mucin16 reduces tumor burden in pancreatic and lung malignancies
A Shah, S Chaudhary, I Lakshmanan, A Aithal, SG Kisling, C Sorrell, ...
NPJ Precision Oncology 7 (1), 74, 2023
Mandates: US National Institutes of Health
Characterization of recombinant β subunit of human MUC4 mucin (rMUC4β)
PG Kshirsagar, M Gulati, WM Junker, A Aithal, G Spagnol, S Das, ...
Scientific reports 11 (1), 23730, 2021
Mandates: US National Institutes of Health
Substituent Effects Impact Surface Charge and Aggregation of Thiophenol-Labeled Gold Nanoparticles for SERS Biosensors
N File, J Carmicheal, AV Krasnoslobodtsev, NC Japp, JJ Souchek, ...
Biosensors 12 (1), 25, 2022
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program